Funnel Chest, Pectus Excavatum
Conditions
Keywords
Nuss, Nuss Procedure, pectus excavatum, cryoanalgesia
Brief summary
The purpose of this study is to determine whether cryoanalgesia provides better pain control for minimally invasive pectus excavatum repair (the Nuss procedure) than thoracic epidural.
Detailed description
Pain control is a major challenge for physicians, who must ensure appropriate and effective pain control for their patients, while remaining mindful of the many negative effects of opioid dependence and addiction. Nowhere is there a more pressing need than in children and young adults, who are at high risk for drug abuse, and in post-operative care, since post-operative opioid use can be a starting point for long-term pain issues. Postoperative pain control in the Nuss procedure, minimally invasive repair of the congenital chest wall deformity known as pectus excavatum, remains a significant problem for the 3000 patients who undergo this procedure each year, mostly adolescents and young adults. Many multimodal analgesic regimens have been tried, but optimal treatment remains unknown. This study will test a novel and promising strategy of using intra-operative cryoanalgesia during the Nuss procedure. Cryoanalgesia is the localized, temporary freezing of peripheral nerves, which is performed at the time of the Nuss procedure. The study is a 20-subject prospective, randomized pilot trial comparing cryoanalgesia to thoracic epidural analgesia for post-operative pain control in patients undergoing the Nuss procedure. Subjects will be recruited from patients already scheduled for a Nuss procedure at our institution, and will undergo 1:1 randomization to either cryoanalgesia or thoracic epidural analgesia for perioperative pain control. During their hospitalization, patients' opiate usage will be prospectively recorded, and pain will be assessed twice per day. Upon discharge, patients will maintain a log of their opiate use, and will return to clinic at 2 weeks, 1 month, 3 months, and 1 year after Nuss procedure for post-operative assessment. Primary outcome is length of perioperative hospitalization, an objective measure that synthesizes many different aspects of a procedure and its subsequent post-operative course, including pain control. Secondary outcomes are post-operative narcotic usage and direct cost of perioperative hospitalization. Side effects of both interventions will also be assessed. This will be the first systematic investigation of cryoanalgesia for local nerve block in a thoracoscopic procedure, and the first study involving its use in adolescents and young adults. The results will have direct application for those undergoing the Nuss procedure to repair pectus excavatum. Investigators will also delineate a reproducible protocol for delivering cryoanalgesia thoracoscopically, to ensure others can safely and effectively use this method if it proves beneficial. Although the focus is on the small subset of patients who undergo the Nuss procedure, if a standardized approach to cryoanalgesia delivery in a thoracoscopic procedure has a positive effect on patient outcomes and cost of hospitalization, the technique could be applied to a variety of surgical procedures, as well as for other neuropathic pain.
Interventions
Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.
Sponsors
Study design
Eligibility
Inclusion criteria
* scheduled for Nuss procedure for pectus excavatum correction * at least 13 years old at the time of the procedure
Exclusion criteria
* age less than 13 years at time of procedure * use of pain medication prior to procedure * pectus carinatum, Poland's syndrome, or any chest wall anomaly other than pectus excavatum * previous repair of pectus excavatum by any technique * previous thoracic surgery * congenital heart disease * bleeding dyscrasia * major anesthetic risk factors or history of previous problem with anesthesia * pregnancy * inability to communicate in English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Length of Hospitalization | estimated one week or less | the length of the patient's in-hospital stay following admission for Nuss procedure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Narcotic Usage | Post Operative Hospital Stay | Inpatient narcotic usage |
| Mean Neuropathic Pain Score at One Year | one year | Neuropathic specific pain (described as burning, electrical or tingling sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible). |
| Cost Analysis | estimated one week | cost analysis of initial hospitalization following Nuss procedure |
Countries
United States
Participant flow
Recruitment details
Twenty consecutive patients were recruited from those scheduled for the Nuss procedure.
Pre-assignment details
Exclusion criteria were age \<13 years, chest wall anomaly other than pectus excavatum, previous repair or other thoracic surgery, and chronic use of pain medications.
Participants by arm
| Arm | Count |
|---|---|
| Cryoanalgesia Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure
Cryoanalgesia | 10 |
| Thoracic Epidural Thoracic epidural (ropivicaine, fentanyl).
Thoracic epidural (ropivicaine, fentanyl): Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl. | 10 |
| Total | 20 |
Baseline characteristics
| Characteristic | Thoracic Epidural | Total | Cryoanalgesia |
|---|---|---|---|
| Age, Categorical <=18 years | 7 Participants | 11 Participants | 4 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 3 Participants | 9 Participants | 6 Participants |
| Age, Continuous | 16.1 years | 18.5 years | 20.9 years |
| Race and Ethnicity Not Collected | — | 0 Participants | — |
| Region of Enrollment United States | 10 Participants | 20 Participants | 10 Participants |
| Sex: Female, Male Female | 2 Participants | 3 Participants | 1 Participants |
| Sex: Female, Male Male | 8 Participants | 17 Participants | 9 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 10 | 0 / 10 |
| other Total, other adverse events | 0 / 10 | 0 / 10 |
| serious Total, serious adverse events | 0 / 10 | 2 / 10 |
Outcome results
Length of Hospitalization
the length of the patient's in-hospital stay following admission for Nuss procedure
Time frame: estimated one week or less
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Cryoanalgesia | Length of Hospitalization | 3 Length of Stay (Post-Operative Days) |
| Thoracic Epidural | Length of Hospitalization | 5 Length of Stay (Post-Operative Days) |
Cost Analysis
cost analysis of initial hospitalization following Nuss procedure
Time frame: estimated one week
Population: Cost analysis was not performed, as these data were not collected.
Mean Neuropathic Pain Score at One Year
Neuropathic specific pain (described as burning, electrical or tingling sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).
Time frame: one year
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Cryoanalgesia | Mean Neuropathic Pain Score at One Year | 2.4 score on a scale | Standard Deviation 2.69 |
| Thoracic Epidural | Mean Neuropathic Pain Score at One Year | 1.9 score on a scale | Standard Deviation 1.34 |
Narcotic Usage
Inpatient narcotic usage
Time frame: Post Operative Hospital Stay
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Cryoanalgesia | Narcotic Usage | 268 mg | Standard Deviation 165.2 |
| Thoracic Epidural | Narcotic Usage | 684 mg | Standard Deviation 191.8 |